Combination therapy with oncolytic virus and adoptively transferred T cells or mRNA vaccine amplifies antitumor effects
RNA-seq (gene expression) · mouse · 24 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 24 samples: 6 × OT1 T cells sorted from B16-OVA tumor treated with PBS, vs 6 × P14 T cells sorted from B16-OVA tumor treated with PBS, vs 6 × OT1 T cells sorted from B16-OVA tumor treated with rVSV-LCMVG, vs 6 × P14 T cells sorted from B16-OVA tumor treated with rVSV-LCMVG,Groups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE235291_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA985647 and SRA study SRP444966. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 24 samples.
How we read this: 4 replicated groups read from 24 sample titles; they account for 24 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7498382 OT1 T cells sorted from B16-OVA tumor treated with PBS, Replicate 1 OT1 T cells sorted from…
- GSM7498383 OT1 T cells sorted from B16-OVA tumor treated with PBS, Replicate 2 OT1 T cells sorted from…
- GSM7498384 OT1 T cells sorted from B16-OVA tumor treated with PBS, Replicate 3 OT1 T cells sorted from…
- GSM7498385 P14 T cells sorted from B16-OVA tumor treated with PBS, Replicate 1 P14 T cells sorted from…
- GSM7498386 P14 T cells sorted from B16-OVA tumor treated with PBS, Replicate 2 P14 T cells sorted from…
- GSM7498387 P14 T cells sorted from B16-OVA tumor treated with PBS, Replicate 3 P14 T cells sorted from…
- GSM7498388 OT1 T cells sorted from B16-OVA tumor treated with rVSV-LCMVG, Replicate 1 OT1 T cells sorted from…
- GSM7498389 OT1 T cells sorted from B16-OVA tumor treated with rVSV-LCMVG, Replicate 2 OT1 T cells sorted from…
- GSM7498390 OT1 T cells sorted from B16-OVA tumor treated with rVSV-LCMVG, Replicate 3 OT1 T cells sorted from…
- GSM7498391 P14 T cells sorted from B16-OVA tumor treated with rVSV-LCMVG, Replicate 1 P14 T cells sorted from…
- GSM7498392 P14 T cells sorted from B16-OVA tumor treated with rVSV-LCMVG, Replicate 2 P14 T cells sorted from…
- GSM7498393 P14 T cells sorted from B16-OVA tumor treated with rVSV-LCMVG, Replicate 3 P14 T cells sorted from…
- GSM7498394 OT1 T cells sorted from B16-OVA tumor treated with PBS, Replicate 1 OT1 T cells sorted from…
- GSM7498395 OT1 T cells sorted from B16-OVA tumor treated with PBS, Replicate 2 OT1 T cells sorted from…
- GSM7498396 OT1 T cells sorted from B16-OVA tumor treated with PBS, Replicate 3 OT1 T cells sorted from…
- GSM7498397 P14 T cells sorted from B16-OVA tumor treated with PBS, Replicate 1 P14 T cells sorted from…
- GSM7498398 P14 T cells sorted from B16-OVA tumor treated with PBS, Replicate 2 P14 T cells sorted from…
- GSM7498399 P14 T cells sorted from B16-OVA tumor treated with PBS, Replicate 3 P14 T cells sorted from…
- GSM7498400 OT1 T cells sorted from B16-OVA tumor treated with rVSV-LCMVG, Replicate 1 OT1 T cells sorted from…
- GSM7498401 OT1 T cells sorted from B16-OVA tumor treated with rVSV-LCMVG, Replicate 2 OT1 T cells sorted from…
- GSM7498402 OT1 T cells sorted from B16-OVA tumor treated with rVSV-LCMVG, Replicate 3 OT1 T cells sorted from…
- GSM7498403 P14 T cells sorted from B16-OVA tumor treated with rVSV-LCMVG, Replicate 1 P14 T cells sorted from…
- GSM7498404 P14 T cells sorted from B16-OVA tumor treated with rVSV-LCMVG, Replicate 2 P14 T cells sorted from…
- GSM7498405 P14 T cells sorted from B16-OVA tumor treated with rVSV-LCMVG, Replicate 3 P14 T cells sorted from…
- GSE235289 Combination therapy with oncolytic virus and adoptively transferred T cells or mRNA vaccine amplifies antitumor effects [RNA-Seq] 12 samples shares combination, transferred, adoptively, oncolytic, amplifies, antitumor, therapy, vaccine
- GSE299507 Combination with oxaliplatin improves abscopal effect of oncolytic virotherapy through reorganization of intratumoral macrophages II 30 samples shares combination, oncolytic, therapy
- GSE299506 Combination with oxaliplatin improves abscopal effect of oncolytic virotherapy through reorganization of intratumoral macrophages 15 samples shares combination, oncolytic, therapy
- GSE299508 Combination with oxaliplatin improves abscopal effect of oncolytic virotherapy through reorganization of intratumoral macrophages III 12 samples shares combination, oncolytic, therapy
- GSE255971 The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models [RNA-seqII] 12 samples shares combination, oncolytic, antitumor
- GSE295238 Combination of HDAC inhibition and cytokine enhances therapeutic HPV vaccine therapy 16 samples shares combination, therapy, vaccine
- GSE275444 Human-correlated genetic HCC and HCC-organoid models identify combination therapy for precision medicine 216 samples shares combination, therapy
- GSE273806 Human-correlated genetic HCC models identify combination therapy for precision medicine 187 samples shares combination, therapy
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.